Medicare Enrolled

Dr. Dany Shamoun, M.D.

Gastroenterology · Orange City, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2884 WELLNESS AVE STE 100, Orange City, FL 32763
3866682221
In practice since 2006 (20 years)
NPI: 1760456677 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shamoun from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shamoun? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shamoun

Dr. Dany Shamoun is a gastroenterology in Orange City, FL, with 20 years in practice. Based on federal Medicare data, Dr. Shamoun performed 2,382 Medicare services across 1,281 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shamoun received a total of $4,638 from 35 pharmaceutical and/or device companies across 226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shamoun is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 10% volume in FL$ $4,638 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,382
Medicare services
Top 10% in FL for gastroenterology
1,281
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~119 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tissue pathology examination, moderate complexity895$27$143
Hospital follow-up visit, high complexity525$96$211
Upper GI endoscopy with biopsy185$55$805
Office visit, established patient (30-39 min)122$100$215
Initial hospital admission, high complexity114$140$413
Removal of polyps or growths of large bowel using an endoscope with mechanical snare99$211$1,058
Colonoscopy with biopsy75$71$936
Special stained specimen slides to identify organisms including interpretation and report73$66$190
Office visit, established patient (20-29 min)42$57$175
Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm39$99$2,152
Special stained specimen slides to examine tissue including interpretation and report32$54$132
New patient office visit (45-59 min)30$126$332
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes29$68$208
Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare28$140$1,015
Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope21$170$503
Diagnostic exam of large bowel using a flexible endoscope14$136$785
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope13$93$633
Hospital follow-up visit, moderate complexity13$64$146
Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope11$209$1,130
Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery11$80$940
New patient office visit (30-44 min)11$52$250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,638
Total received (2018-2024)
Avg $663/year across 7 years
Top 36% in FL for gastroenterology
35
Companies
226
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,638 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$906
2023
$679
2022
$267
2021
$448
2020
$321
2019
$458
2018
$1,560

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Covidien LP
$1,026
AbbVie Inc.
$687
ABBVIE INC.
$393
AbbVie, Inc.
$345
PFIZER INC.
$250
Gilead Sciences, Inc.
$198
Janssen Biotech, Inc.
$166
Olympus America Inc.
$154
Phathom Pharmaceuticals, Inc.
$152
Allergan Inc.
$131
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$113
Ferring Pharmaceuticals Inc.
$83
Takeda Pharmaceuticals U.S.A., Inc.
$79
UCB, Inc.
$70
GENZYME CORPORATION
$62
Shionogi Inc
$60
Intercept Pharmaceuticals, Inc.
$56
RedHill Biopharma Inc.
$53
Braintree Laboratories, Inc.
$49
Regeneron Healthcare Solutions, Inc.
$48
Nestle HealthCare Nutrition Inc.
$47
QOL Medical, LLC
$42
VIVUS LLC
$40
Synergy Pharmaceuticals Inc
$38
Celgene Corporation
$37
Alnylam Pharmaceuticals Inc.
$37
Ironwood Pharmaceuticals, Inc
$36
Allergan, Inc.
$31
AIMMUNE THERAPEUTICS, INC.
$31
Celltrion USA Inc.
$28
Merck Sharp & Dohme Corporation
$22
Enterra Medical, Inc.
$21
EAGLE PHARMACEUTICALS, INC.
$19
Daiichi Sankyo Inc.
$19
Madrigal Pharmaceuticals
$18
Top 3 companies account for 45.4% of total payments
Associated products mentioned in payments ›
APRISO · Amitiza · BARHEMSYS · Barrx · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EndoClot PHS · HUMIRA · Humira · INJECTAFER · LINZESS · Linzess · MAVYRET · MOVIPREP · Mavyret · Movantik · Mulpleta · OCALIVA · ONPATTRO · Olympus · QSYMIA · Qsymia · RELISTOR · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUTAB · Smart Pill · Symproic · TREMFYA · Talicia · Trulance · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $195 per 100 Medicare services performed
Looking for a gastroenterology in Orange City?
Compare gastroenterologys in the Orange City area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
59
Per 100K population
10.4
County median income
$66,581
Nearest hospital
ADVENTHEALTH FISH MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shamoun is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shamoun experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Shamoun performed 895 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shamoun receive payments from pharmaceutical companies?
Yes. Dr. Shamoun received a total of $4,638 from 35 companies across 226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shamoun's costs compare to other gastroenterologys in Orange City?
Dr. Shamoun's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shamoun) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →